Skip to main content

Table 2 Patient profiles and transplanted SVF information

From: Innovative method of alopecia treatment by autologous adipose-derived SVF

Subject’s No

Age

Sex

Stage

Aspirated adipose tissue/cc

Harvested SVF volume/cc

Live SVF cells × 106/cc

Injected live cells × 106/48 spot

1

51

M

Class IV

70.2

15.4

1.62

9.55

2

51

Class IV

90

17.0

1.62

7.68

3

54

Class V

80

17.0

0.65

7.68

4

56

Class V

90

17.0

0.69

7.68

5

43

F

Class II

90

14.6

1.01

7.68

6

44

Class II

90

17.0

1.22

7.68

7

48

Class I

90

15.3

1.29

7.68

8

59

Class II

80

17.0

1.32

7,68

9

64

Class III

90

16.0

2.15

7.68

  1. The viability of SVF cells was 95.4 ± 3.6% (range 91.8–99%) before and after needle injection